Curare

What Curare does

Curare is a privately held, for-profit boutique consultancy founded in 2015 and headquartered in Liempde, Netherlands, that offers translational and clinical drug development services across various therapeutic modalities. The firm positions itself as a specialist support partner to biopharma and life sciences organizations navigating the transition from preclinical research through clinical development. Its stated scope covers multiple therapeutic modalities, implying breadth across small molecules, biologics, or other drug classes, though the exact modalities served are not detailed in the available data.

The company operates with a lean team of 1-10 employees, structured around its three co-founders: Edwin Spaans (Principal Consultant), Ellen Hulskotte (Partner), and Tonke Bragt (Partner). This founding-partner-led model indicates a high-touch, expertise-driven consulting model rather than a scalable technology platform. There is no disclosed information on proprietary tools, technology stack, or platform architecture; the firm's primary assets are the scientific and clinical expertise of its leadership.

Curare's go-to-market is not documented in the source material. The public website (curareconsulting.com) presents only a verification/loading placeholder with no accessible product, pricing, customer, or marketing information. No revenue, funding, customer logos, partnerships, patents, awards, geographic footprint, or pricing model have been disclosed. As a result, the business mechanics — how Curare acquires clients, structures engagements, and prices services — cannot be characterized beyond the inference of a relationship-driven, referral-based boutique consultancy typical of sub-10-person European life sciences advisory firms.

Name

Curare

Website

https://curareconsulting.com

Company type

Private

Founded year

2015

Headcount range

1–10 employees

Short description

Curare is a privately held, Netherlands-based boutique consultancy (1-10 employees, founded 2015) that provides translational and clinical drug development support across multiple therapeutic modalities to biopharma clients.

Ownership category

akta.pro rank

Product category

Pharmaceutical Consulting

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Management Consulting Services (8742)

akta.pro primary industry

Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL)

akta.pro secondary industries

Clinical Research Support (CRC/CTA) (EDAOAJAO), Regulatory Strategy & IND/NDA/BLA Submissions Support (HLAIALAH)

Keywords

• Drug development consulting
• Clinical development services
• Translational research consulting
• Pharmaceutical consulting
• Therapeutic consulting

Headquarters

HQ city

Liempde

HQ country

Netherlands

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales

Core offering

Curare offers translational and clinical drug development consulting services across various therapeutic modalities. The firm supports pharmaceutical and biotechnology clients with expertise spanning the drug development lifecycle, from translational research through clinical stages.

Differentiator

Problem solved

Functional benefit

Products and services

• Drug Development Consulting Translational and clinical drug development consulting services spanning various therapeutic modalities, serving pharmaceutical and biotechnology clients that require expert guidance across the drug development lifecycle.

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves1 record

Expansion highlights1 record

Broad incumbents

• IQVIA: IQVIA is the world's largest CRO and clinical development services provider. It is comparable to Curare as it offers clinical drug development services to biotech and pharma sponsors, but at vastly greater scale and across the full clinical-commercial continuum.
• ICON plc: ICON is a leading global CRO providing clinical research, consulting, and translational services across therapeutic areas. Comparable to Curare in the clinical drug development services category, though operating at far greater scale and geographic reach.
• Charles River Laboratories: Charles River provides early-stage and clinical CRO services, including translational biology and drug development support. Comparable to Curare in the translational-to-clinical development value chain, though at much larger scale with broad scientific depth.
• Parexel: Parexel is a global clinical CRO and biopharmaceutical services firm with a strong biotech sponsor book. Comparable to Curare in offering clinical drug development services to biotechs, although it operates across far more geographies and modalities.
• Medpace Holdings: Medpace is a mid-to-large CRO focused on full-service clinical development for emerging and mid-sized biopharma. Comparable to Curare in clinical development services targeting biotech sponsors, though with much larger operational footprint.
• Syneos Health: Syneos Health is a fully integrated biopharmaceutical solutions organization offering clinical development and commercialization services. Comparable to Curare in clinical drug development services, though operating across the full development-to-commercialization continuum.

Direct peers

• Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-sized global CRO focused on complex clinical development across multiple therapeutic areas. Comparable to Curare as a multi-modality clinical drug development services provider, though at significantly greater scale.
• Celerion: Celerion is a specialty CRO focused on early-stage clinical pharmacology and translational research. Comparable to Curare in its emphasis on translational-to-early-clinical drug development, though with deeper laboratory and Phase I infrastructure.
• ProPharma Group: ProPharma Group is a life sciences consulting and CRO services provider offering clinical development, regulatory, and compliance consulting to biotech and pharma. Comparable to Curare in combining clinical development consulting with regulatory strategy for biotech sponsors.
• CTI Clinical Trial & Consulting Services: CTI Clinical Trial & Consulting is a specialty CRO focused on clinical research and drug development consulting across multiple therapeutic areas. Comparable to Curare in offering multi-modality clinical drug development services to biotech sponsors.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat2 records

Key risks4 records

Key highlights4 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Curare